RU2020133816A3 - - Google Patents
Download PDFInfo
- Publication number
- RU2020133816A3 RU2020133816A3 RU2020133816A RU2020133816A RU2020133816A3 RU 2020133816 A3 RU2020133816 A3 RU 2020133816A3 RU 2020133816 A RU2020133816 A RU 2020133816A RU 2020133816 A RU2020133816 A RU 2020133816A RU 2020133816 A3 RU2020133816 A3 RU 2020133816A3
- Authority
- RU
- Russia
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/22—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
- C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
- C07K2317/622—Single chain antibody (scFv)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Ophthalmology & Optometry (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862643887P | 2018-03-16 | 2018-03-16 | |
| US62/643,887 | 2018-03-16 | ||
| US201962805344P | 2019-02-14 | 2019-02-14 | |
| US62/805,344 | 2019-02-14 | ||
| PCT/IB2019/051899 WO2019175727A1 (en) | 2018-03-16 | 2019-03-08 | Methods for treating ocular diseases |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2022116645A Division RU2022116645A (ru) | 2018-03-16 | 2019-03-08 | Способы лечения глазных заболеваний |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| RU2020133816A RU2020133816A (ru) | 2022-04-18 |
| RU2020133816A3 true RU2020133816A3 (https=) | 2022-04-18 |
| RU2776850C2 RU2776850C2 (ru) | 2022-07-27 |
Family
ID=
Also Published As
| Publication number | Publication date |
|---|---|
| CA3091096A1 (en) | 2019-09-19 |
| JP6938796B2 (ja) | 2021-09-22 |
| MX2020009140A (es) | 2020-09-28 |
| AU2021286278A1 (en) | 2022-01-20 |
| AU2021286278C1 (en) | 2024-05-23 |
| AU2021286278B2 (en) | 2023-09-14 |
| IL277333B1 (en) | 2025-11-01 |
| IL277333A (en) | 2020-10-29 |
| JP2021191778A (ja) | 2021-12-16 |
| RU2020133816A (ru) | 2022-04-18 |
| JP2021509912A (ja) | 2021-04-08 |
| US20210017266A1 (en) | 2021-01-21 |
| EP3765083A1 (en) | 2021-01-20 |
| JP2024042697A (ja) | 2024-03-28 |
| CN111867631A (zh) | 2020-10-30 |
| TWI727279B (zh) | 2021-05-11 |
| KR20260036043A (ko) | 2026-03-13 |
| AU2019235577A1 (en) | 2020-08-27 |
| AU2019235577B2 (en) | 2021-09-30 |
| WO2019175727A1 (en) | 2019-09-19 |
| KR20200131839A (ko) | 2020-11-24 |
| IL277333B2 (en) | 2026-03-01 |
| TW201945027A (zh) | 2019-12-01 |
| IL323849A (en) | 2025-12-01 |